Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Chlorhexidine glucon 2%/Isopropyl alcohol 70% soln 0.67ml
1311020L0AABWBW
|
Chlorhexidine gluconate (Topical cleanser) | Chlorhexidine gluconate | Skin | 1 |
|
Chlorhexidine gluconate 0.05% irrig soln 1litre bags
1311020L0AABUBU
|
Chlorhexidine gluconate (Topical cleanser) | Chlorhexidine gluconate | Skin | 1 |
|
Chlorhexidine gluconate 5% solution
1311020L0AAAKAK
|
Chlorhexidine gluconate (Topical cleanser) | Chlorhexidine gluconate | Skin | 1 |
|
Clobet .05% crm 25%/Propylene glycol 40% in Gen Unguen M crm
1304000G0AADPDP
|
Clobetasol propionate | Clobetasol propionate | Skin | 1 |
|
Clobetasol 0.05% ointment 50% in White soft paraffin
1304000G0AACGCG
|
Clobetasol propionate | Clobetasol propionate | Skin | 1 |
|
Coal tar 10% / Salicylic acid 5% in Aqueous cream
1305020C0AAFVFV
|
Coal tar/tar (Topical) | Tars | Skin | 1 |
|
Coal tar 12% in White soft paraffin
1305020C0AAELEL
|
Coal tar/tar (Topical) | Tars | Skin | 1 |
|
Coal tar 12%/Salicylic acid 3% in Clobetasone 0.05%
1304000H0AACRCR
|
Clobetasone butyrate (Topical) | Clobetasone butyrate | Skin | 1 |
|
Coal tar 25% in Yellow soft paraffin
1305020C0AAEFEF
|
Coal tar/tar (Topical) | Tars | Skin | 1 |
|
Coal tar paste
1305020C0AAFEFE
|
Coal tar/tar (Topical) | Tars | Skin | 1 |
|
Coal tar soln 10% / Salic acid 2% in Betameth val 0.1% oint
1305020I0AAAGAG
|
Coal tar and corticosteroids | Coal tar and corticosteroid preparations | Skin | 1 |
|
Coal tar solution 10% cream
1305020C0AAARAR
|
Coal tar/tar (Topical) | Tars | Skin | 1 |
|
Coal tar solution 10% in Yellow soft paraffin
1305020C0AADXDX
|
Coal tar/tar (Topical) | Tars | Skin | 1 |
|
Coal tar solution 5% in Clobetasone 0.05% ointment
1304000H0AACNCN
|
Clobetasone butyrate (Topical) | Clobetasone butyrate | Skin | 1 |
|
Coal tar solution 6% in White soft paraffin
1305020C0AAEYEY
|
Coal tar/tar (Topical) | Tars | Skin | 1 |
|
Cymex Ultra 5% cream
1310030C0BNAAAA
|
Cymex (Aciclovir) | Aciclovir | Skin | 1 |
|
Dermovate-NN cream
1304000G0BBAFCA
|
Dermovate | Clobetasol propionate | Skin | 1 |
|
Dermovate-NN ointment
1304000G0BBAGCB
|
Dermovate | Clobetasol propionate | Skin | 1 |
|
Dithranol 0.1% in Zinc and Salicylic acid paste
1305020F0AAETET
|
Dithranol (Topical) | Dithranol | Skin | 1 |
|
Dithranol 0.5% in Zinc and Salicylic acid paste
1305020F0AAFAFA
|
Dithranol (Topical) | Dithranol | Skin | 1 |
|
Dovonex 50micrograms/g cream
1305020D0BBABAB
|
Dovonex | Calcipotriol | Skin | 1 |
|
Elave body wash
130201100BBBBA0
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | 1 |
|
Elena's Day Cream Special and Night Cream Extra
130501000BBBIA0
|
Proprietary compound preparation BNF 1305010 | Other eczema preparations | Skin | 1 |
|
Elena's Ultimate Body Oil liquid
130501000BBBEA0
|
Proprietary compound preparation BNF 1305010 | Other eczema preparations | Skin | 1 |
|
EN-Potab 400mg tablets for cutaneous solution
1311060Q0BCAAAC
|
EN-Potab | Potassium permanganate | Skin | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.